Semaglutide lowered serious heart trouble among people living with heart disease.

What Semaglutide may change

Semaglutide may lower blood sugar, body weight, and certain heart risks. It acts like GLP-1, the hormone your gut sends out after food. Doctors prescribe it for type 2 diabetes, long-term weight care, or some heart risks. A serious fatty liver illness became another use in 2025.

Patients may get a weekly shot or take a pill each day. Large studies found weight loss, steadier sugar, and fewer severe heart problems; nausea and bowel trouble were most common early in care. Read the effects and safety findings before you discuss options with your doctor.

What changed in the large studies

SELECT enrolled 17,604 people who had heart trouble and carried extra weight; none had diabetes. Its findings came out in 2023. A 2.4 mg weekly shot cut by 20% the combined total of deaths due to heart trouble, heart attacks, and strokes. The comparison group received a placebo, a look-alike shot without semaglutide ^[3]. A result of 1 would mean no difference. The paper's 95% range shows how far the group result might reasonably move; the whole range favored semaglutide, so this finding was firm.

An earlier study found a like result. In 2016, SUSTAIN-6 followed 3,297 people with type 2 diabetes whose heart risk was high. Those three grave heart problems were about a quarter less common. Its 95% range favored semaglutide, though the size of the benefit was less sure. Serious diabetic eye trouble occurred more often ^[2]; that 95% range favored more trouble, but its width left the amount unsure. In PIONEER 6, the pill did not raise the risk of serious heart problems ^[8].

STEP 1 also measured weight. People using a 2.4 mg weekly shot lost 14.9% of their starting weight on average over 68 weeks; the placebo group lost 2.4% ^[1]. Waist size, blood pressure, blood fats, blood sugar, and signs of swelling also improved ^[10].

What makes one shot last a week

Semaglutide is a semaglutide peptide, a small protein used as medicine. It copies GLP-1, a natural gut hormone. A 94% match means most of its parts resemble GLP-1. Scientists changed the protein part they call 8, so an enzyme called DPP-4 cuts up the medicine more slowly. Another change lets it ride on a blood protein, slowing kidney removal ^[17].

Natural GLP-1 disappears from the body in about two minutes. Semaglutide's effect can last seven days, so one shot may cover a week. Mouse and rat tests found medicine in brain areas that steer hunger ^[4]. Those animals ate smaller meals and picked new foods, without burning less energy. Read how Semaglutide works for the split between animal and human evidence.

Where Semaglutide care and facts come from

This is a naturalist's notebook on the record — it sells no semaglutide, prescribes nothing, and runs no clinic. The prescribing happens elsewhere: semaglutide is a prescription-only medicine, and in the US that access runs through a licensed clinician — a physician's office, or a telehealth practice such as Promise Peptides (mypromise.com), whose clinicians prescribe semaglutide after an evaluation rather than on request. This notebook's only job is the record. It logs what the peer-reviewed trials measured and what the research-use community reports, and it points you to the primary sources so you can read them yourself. Every quantitative claim here — every hazard ratio, every percentage, every n-value — is tied to a numbered citation you can follow on the Semaglutide references page.

If you want the human texture — the appetite that goes quiet, the sulfur burps, the nausea that peaks during titration — the Semaglutide effects page gathers the reported benefits and side effects, labeled plainly as anecdote, alongside the cited safety cautions. The kidney, liver, and head-to-head comparison data live in the research notes.